As soon as they were introduced, the pharmacokinetics of antibiotics became a subject of interest. There are two reasons for this. First, the relationship between concentration and antibacterial effect can easily be established in vitro, and, second, plasma concentrations in patients can be measured relatively easily by bioassay. This led to early insight into the relationship between in vivo pharmacokinetics and effective concentrations in vitro. For instance, the very rapid excretion of penicillin by the kidney was perceived soon after introduction of this drug, the corollary of this finding being that effective concentrations in the body can be maintained for only a short period after administration. For this reason the very low doses of penicillin administered at that time were given frequently, even continuously. Pharmacokinetics as a science has progressed since those early days, but it remains to be seen whether this has also led to a more rational approach to antibiotic dosages. The intention of this short review is not to discuss all possible aspects of the pharmacokinetics of antibiotics but rather to consider those that are relevant to the clinical administration of antibiotics on the basis of their pharmacodynamics.The most common parameter of the efficacy of antibiotics in vitro is the minimal inhibitory concentration (MIC), sometimes supplemented by the minimal bactericidal concentration. However, although the MIC is very useful for simple screening as well as decision making in clinical practice, it does not lead to an understanding of the relationship between a range of concentrations and effects in time. Moreover, it has become apparent that the effect of the antibiotic at the MIC should not be regarded as either the minimal antibacterial effect -not even in vitro -or the maximal effect. A more relevant parameter of the relationship between concentration and effect is the killing rate, or the rate of the inhibition of growth of the bacteria, because this is a continuous variable dependent on concentration. This parameter can indeed be quantified in terms of potency and efficacy; in this terminology, potency defines the concentration range within which the antibacterial effect increases from zero to maximal, and efficacy indicates the magnitude of the maximal bacteriostatic or bactericidal effect itself. Another pharmacodynamic parameter, which is particularly important for gram-positive bacteria, is the postantibiotic effect. This considers that, at least in vitro, inhibition of bacterial growth continues for some time after the antibiotic has been removed from the medium [2]. This phenomenon is not limited to the field of antibiotics, and in pharmacological terminology it has been known for some time under the name of hysteresis.Present knowledge of the relationship between concentration and effect in time results from research that has focused on beta-lactam antibiotics and aminoglycosides. Beta-lactam antibiotics are characterized by a steep concentration-effect curve in vitro [9], which means...